News
Media enquiries
For all media enquiries, contact our Marketing and Communications team.
Social and Behavioural Sciences
The Social and Behavioural Sciences team
Our Social and Behavioural Sciences team are experts in advising researchers on what steps they should take to protect their intellectual property and create robust innovations to attract industry investment.
Social and Behavioural Sciences Technologies
YOLO: a mental health promotion program for university students
A web-based intervention for university students experiencing mental health distress
iAx
Fast-tracking assessment to treat patients with substance-use disorders
Take Five
An animated educational resource that reduces procedural anxiety in paediatric burns patients and their carers
Triple P – Positive Parenting Program® (Triple P)
A world-renowned program that aims to equip parents with the skills, strategies and confidence to handle any parenting situation
Bullying & Cyberbullying Scale for Adolescents
A self-report survey tool that measures bullying behaviour among adolescents
Parent Cough Specific Quality of Life
Measurement questionnaire of the impact of a child's cough on parental wellbeing and daily life
Geriatric Anxiety Inventory
A simple self-reporting scale for quickly screening older people for anxiety disorders
BRAVEâ„¢
An interactive cognitive behavioural therapy program developed specifically for anxious children, teens and their parents
Latch-On®
Latch-On® enables young adults with intellectual disabilities continue their literacy development in a post-school environment

Head of Social and Behavioural Sciences
Anne Bannister
Anne is a senior management professional who specialises in commercialising UQ's evidence-based technologies and programs to transform the way global communities tackle issues such as parenting, mental health, education and ageing. With previous executive management roles across commercial and charitable organisations, her expertise in building businesses based on commercialised IP was developed in her own startup.
Innovation Pipelines
We have a suite of available technologies to give your business an innovative edge.
Life Sciences
The Life Sciences team
Our Life Sciences team are experts in advising researchers on what steps they should take to protect their intellectual property and create robust innovations to attract industry investment.
Life Sciences Technologies
Focused ultrasound for treatment of neurodegenerative disease
A non-invasive technology for treatment of brain diseases including Alzheimer's disease
Method for stable integration of genes that boosts product expression in yeast
Method to increase expression yields
Modulators of Class IIa HDACs
New potent and selective inhibitors of class IIa HDAC enzymes
Clec9a targeted vaccination for virus-mediated autoimmune disease
Novel approach to prevent progression of viral-associated autoimmune diseases
IBD therapeutic derived from gut microbial metabolites
IBD therapeutic with comparable reduction in disease severity to biologic therapies
Peptide activator of ACE-2 for kidney diseases and inflammation
A peptide derived from snake venom that is useful for the treatment of kidney diseases and inflammation.Â
Knock-in genetic barcodes for multiplexed single-cell sequencing
A method for barcoding human cells with proprietary barcodes
Potent and selective inhibitors of human β-factor XIIa
A potential therapeutic strategy for the safe prevention of artificial surface-induced thrombosis.
CAST gene editing platform
Enabling genomic integration of heterologous gene sequences or single base editing

Head of Life Sciences
Craig Belcher
Craig is a senior management professional with more than 20 years' experience in commercialising technology within the biotechnology and nanotechnology industries. He leads a team that identifies, patents and commercialises intellectual property from The University of Queensland related to human health, from therapeutics to diagnostics, genomics and the microbiome, to medical devices, as well as biological sciences, food and agriculture.
Innovation Pipelines
We have a suite of available technologies to give your business an innovative edge.
Impact Highlights
Our impact
Read more about UniQuest’s achievements in the stories below.
Innovation Pipeline
We have a suite of available technologies and discoveries to give your business an innovative edge.
Physical Sciences
The Physical Sciences team
Our Physical Sciences team are experts in advising researchers on what steps they should take to protect their intellectual property and create robust innovations to attract industry investment.
Physical Sciences Technologies
The future of copper production
A simpler, cheaper process avoiding high temperature smelter
Controlled release nano-termiticide formulation
A nano-termiticide application to protect buildings from termite infestation.
Quantum Link Verification
An approach to verify the physical security of fibre optic cabling using quantum technology
Removal of radioactive contamination in mining
Efficient process for the removal of radioactive contamination in mining.
Perovskite composite material with improved optical properties and stability
New class of composite material which enhances the optical properties and stability of perovskites
High strength, high conductivity, copper alloy
Copper alloys for 3D printing
High strength, high ductility, titanium alloy
Titanium alloys for 3D printing
Psychomotor Vigilance Task (PVT) test alternative
A novel method for assessing neuropsychological impairment using electroencephalogram (EEG)
SnoreSounds/Sleep Apnea Assessment
Screening Obstructive Sleep Apnea syndrome using a mobile phone platform

Head of Physical Sciences
Alister Morrison
Alister Morrison joined UniQuest in 2018 and manages the Physical Sciences Commercialisation Team. Alister is a senior management professional with over twenty years of strategic international experience. He has held senior career roles in mergers and acquisitions, economics, business development, strategy, planning and technical asset development with Gulf Keystone Petroleum and Pioneer Natural Resources.
Innovation Pipelines
We have a suite of available technologies to give your business an innovative edge.
Industry Impact
$959m+
Raised to take university technology to market
150+
Active licence agreements
$53b+
Gross product sales of licensed
UQ technologies
$923m+
In revenue returned to UQ since 2002
125+
Companies created from our intellectual property portfolio
360+
Granted US patents
Impact highlights
Our commercialisation impact makes The University of Queensland Australia’s top university for licence income and value of equity held in spin-out companies.*
*National Survey of Research Commercialisation, Department of Industry, Innovation and Science, 2021

Gardasil®: A global solution to eradicating cervical cancer
The Gardasil® cervical cancer vaccine has led to a decrease of approximately 90 per cent in the prevalence of human papillomavirus (HPV), the major cause of cervical cancer.

UQ technology with the power to revolutionise global vaccine delivery
Vaxxas Pty Ltd is set to revolutionise vaccine delivery through its innovative High-Density Microarray Patch (HD-MAP).

Encapsulated probiotic drink a world first
The world’s first encapsulated probiotic drink uses patented micro-shield technology to deliver targeted in-gut release of effective probiotics.

A smartphone app helping doctors and patients breathe easier
Just one cough and a simple and inexpensive new smartphone technology can instantly and accurately identify respiratory diseases.

Bringing the benefits of positive parenting to the world
The Triple P-Positive Parenting Program is changing the lives of millions of families around the world and helping to build stronger, more resilient communities.

MRI scan technology is savings lives around the world
UQ’s innovative technology, which is used in most of the world’s MRI machines, has helped more than 8 billion people across the globe.
Contact our team
UniQuest has access to over 7000+ UQ researchers with research at or above world standard across 30 research strength areas.
Innovation Pipelines
In partnership with researchers at The University of Queensland, UniQuest creates impact through the commercialisation of UQ intellectual property.
Our specialised team deliver high quality technology transfer expertise and can help you access the world class research and intellectual property of UQ. We have a suite of available technologies and discoveries at our fingertips to give your business an innovative edge.
Discover more products on the UniQuest eShop. The eShop provides access to a broad range of products that have been developed by researchers at The University of Queensland (UQ).
Pharma & MedTech
UniQuest’s innovation portfolio includes Australia's first blockbuster vaccine Gardasil® and start-up companies Spinifex Pharmaceuticals Inc and Inflazome Ltd, which were acquired in two of the largest university start-up exits in Australian history.
Agriculture & Food
UniQuest’s innovation portfolio delivers the latest scientific breakthroughs in crops and horticulture, plant diseases and pest control, as well as post-harvest food, animal health and production technologies.
Physical Sciences
UniQuest’s innovation portfolio includes UQ’s superconductor technology which is used in most of the world’s MRI machines, and offers breakthrough technologies in electric vehicle batteries, sensors, UAVs and robotics, big data, space technologies and advanced materials.
Social and Behavioural Sciences
UniQuest’s innovation portfolio delivers evidence-based solutions at the intersection of human behaviour and the social environment to enable better communities, education, health and wellbeing.
Available Technology
We have a suite of available technologies to give your business an innovative edge.
Team
Board and Management
Rovid quam, tem sequia audignis el maion perum landite modiam quam aborpos maxim es que consequid molut quis voloresto voluptatiam nim ullique nonsequiatet fuga. Ut omnimporis dolo omnihicabor mi, sapicil itatesciis conemquides andicae storero dolesci omniet, volecep erspid unt magnis esciumquae audi optatum ex et.
Our Staff
Rovid quam, tem sequia audignis el maion perum landite modiam quam aborpos maxim es que consequid molut quis voloresto voluptatiam nim ullique nonsequiatet fuga. Ut omnimporis dolo omnihicabor mi, sapicil itatesciis conemquides andicae storero dolesci omniet, volecep erspid unt magnis esciumquae audi optatum ex et.
Contact UniQuest
Uciministi sequatur sanis dolori con excepta cumquis qui rem libusda si ut ut ex eniendi psundisqui berio cor aliquias eum ium inctem aut as escium ium expligenimin praturiberum fugiam hictore iciunti cusciment molor
Available Technologies

Physical Sciences
Physics, engineering (chemical, civil, electrical, mechanical and mining), geoscience, information and communications technology (ICT), artificial intelligence (AI), materials science, nanotechnology

Social + Behavioural Sciences
Evidence-based solutions at the intersection of human behaviour and the social environment to enable better communities, education, health and wellbeing.
Available Technologies
UniQuest is Australia’s leading technology transfer company.
Our specialised team delivers high-quality commercialisation expertise to connect industry with the world-class research and intellectual property of The University of Queensland.
Our suite of available technologies can give your business an innovative edge.
Innovation Pipelines
We have a suite of available technologies to give your business an innovative edge.
Industry
Australia’s leading research commercialisation company
UniQuest manages the intellectual property of The University of Queensland.
News
UQ research into developing new treatments for conditions such as cancer, inflammatory diseases and type 1 diabetes has received recognition and funding support from a national incubator for biomedical startup companies.
Working in partnership with University of Queensland researchers, UQ commercialisation company UniQuest has secured $3 million in funding for the four startups under the first round of the Medical Research Future Fund (MRFF)’s national $40 million CUREator Scheme.
Events
Industry Connect
Industry Connect events enable pre-qualified collaborations between industry and researchers.
Workshop
We host free, two-day Research Commercialisation Workshops for UQ’s early-career researchers.
Impact Stories
From idea to impact, UniQuest commercialises UQ research to create change.

Gardasil®: A global solution to eradicating cervical cancer
From its origins in groundbreaking research at The University of Queensland, to its use in more than 130 countries worldwide, the Gardasil® cervical cancer vaccine has led to an approximate 90 per cent decrease in the prevalence of human papillomavirus (HPV), the major cause of cervical cancer.

Better gut health with the world's first encapsulated probiotic drink
The world’s first encapsulated probiotic drink uses patented technology to deliver beneficial bacteria safely to the gut. PERKii® is sold in more than 2000 stores across Australia and New Zealand.

Bringing the benefits of positive parenting to the world
The Triple P-Positive Parenting Program is changing the lives of millions of families around the world, thanks to the work of leading researchers at UQ and the acumen of licensee Triple P International Pty Ltd.
Available technologies
Our specialised team delivers the highest quality commercialisation expertise and can help you access the world class research, resources and intellectual property of The University of Queensland. We have a suite of available technologies and discoveries for licensing or investment.